HEADER TRANSFERASE 01-FEB-07 2OQT TITLE STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF A PUTATIVE PTS IIA TITLE 2 DOMAIN FROM STREPTOCOCCUS PYOGENES M1 GAS COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL PROTEIN SPY0176; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PYOGENES SEROTYPE M1; SOURCE 3 ORGANISM_TAXID: 301447; SOURCE 4 STRAIN: M1 GAS, SF370; SOURCE 5 ATCC: 700294; SOURCE 6 GENE: SPY0176; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PMCSG19 KEYWDS APC29699, PUTATIVE PTS IIA DOMAIN, STREPTOCOCCUS PYOGENES M1 GAS, KEYWDS 2 STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST KEYWDS 3 CENTER FOR STRUCTURAL GENOMICS, MCSG, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.TAN,R.WU,J.OSIPIUK,S.CLANCY,A.JOACHIMIAK,MIDWEST CENTER FOR AUTHOR 2 STRUCTURAL GENOMICS (MCSG) REVDAT 4 09-OCT-24 2OQT 1 REMARK REVDAT 3 27-DEC-23 2OQT 1 SEQADV LINK REVDAT 2 24-FEB-09 2OQT 1 VERSN REVDAT 1 06-MAR-07 2OQT 0 JRNL AUTH K.TAN,R.WU,J.OSIPIUK,S.CLANCY,A.JOACHIMIAK JRNL TITL THE CRYSTAL STRUCTURE OF A PUTATIVE PTS IIA DOMAIN FROM JRNL TITL 2 STREPTOCOCCUS PYOGENES M1 GAS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 3 NUMBER OF REFLECTIONS : 22509 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1196 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.41 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.47 REMARK 3 REFLECTION IN BIN (WORKING SET) : 936 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE SET COUNT : 44 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4645 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09000 REMARK 3 B22 (A**2) : 0.05000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.05000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.593 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.295 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.221 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.172 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4763 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6502 ; 1.927 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 617 ; 7.837 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;40.063 ;25.543 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 813 ;23.361 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;22.087 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 795 ; 0.138 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3502 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2428 ; 0.258 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3262 ; 0.314 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 164 ; 0.167 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 42 ; 0.198 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 1 ; 0.014 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3155 ; 1.025 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4996 ; 1.696 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1800 ; 2.263 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1501 ; 3.561 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2OQT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041473. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97924, 0.97938 REMARK 200 MONOCHROMATOR : SI 111 CRYSTAL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23714 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 35.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 34.8600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 52.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.54200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.020 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2M LI2SO4, PH 6.7, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 56.39050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). AUTHORS STATE THAT THE REMARK 300 BIOLOGICAL UNIT OF THIS POLYPEPTIDE IS A MONOMER. REMARK 300 SEE REMARK 350 FOR INFORMATION ON GENERATING THE REMARK 300 BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 72 REMARK 465 PRO A 152 REMARK 465 TYR A 153 REMARK 465 LEU A 154 REMARK 465 GLU A 155 REMARK 465 GLY A 156 REMARK 465 MSE A 157 REMARK 465 ASP A 158 REMARK 465 LEU A 159 REMARK 465 ASN A 160 REMARK 465 ALA A 161 REMARK 465 SER B 151 REMARK 465 PRO B 152 REMARK 465 TYR B 153 REMARK 465 LEU B 154 REMARK 465 GLU B 155 REMARK 465 GLY B 156 REMARK 465 MSE B 157 REMARK 465 ASP B 158 REMARK 465 LEU B 159 REMARK 465 ASN B 160 REMARK 465 ALA B 161 REMARK 465 LEU C 154 REMARK 465 GLU C 155 REMARK 465 GLY C 156 REMARK 465 MSE C 157 REMARK 465 ASP C 158 REMARK 465 LEU C 159 REMARK 465 ASN C 160 REMARK 465 ALA C 161 REMARK 465 GLY D 156 REMARK 465 MSE D 157 REMARK 465 ASP D 158 REMARK 465 LEU D 159 REMARK 465 ASN D 160 REMARK 465 ALA D 161 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 82 CA - CB - CG ANGL. DEV. = 14.7 DEGREES REMARK 500 LEU B 103 CA - CB - CG ANGL. DEV. = 15.5 DEGREES REMARK 500 LEU C 73 CA - CB - CG ANGL. DEV. = 19.5 DEGREES REMARK 500 PRO C 152 C - N - CA ANGL. DEV. = 18.2 DEGREES REMARK 500 PRO C 152 C - N - CD ANGL. DEV. = -15.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 32 -8.28 -54.75 REMARK 500 LYS A 37 27.96 49.29 REMARK 500 MSE A 66 79.08 -115.65 REMARK 500 ASP A 126 120.04 -28.16 REMARK 500 SER A 137 147.15 -175.75 REMARK 500 MSE B 1 103.17 -27.20 REMARK 500 ILE B 8 -75.99 -63.73 REMARK 500 ASP B 9 -27.80 -32.87 REMARK 500 LYS B 37 20.06 43.31 REMARK 500 MSE B 66 74.97 -119.37 REMARK 500 GLU B 70 89.57 -16.53 REMARK 500 ALA B 71 82.43 -58.47 REMARK 500 LYS B 87 126.39 158.73 REMARK 500 SER B 92 6.48 -57.06 REMARK 500 ASP B 107 125.51 -171.90 REMARK 500 MSE C 1 68.80 -107.06 REMARK 500 ARG C 77 123.25 143.10 REMARK 500 SER C 151 -76.99 -128.18 REMARK 500 ASP D 35 -5.77 -52.28 REMARK 500 PRO D 62 125.30 -22.26 REMARK 500 GLU D 70 12.25 -63.09 REMARK 500 ALA D 71 -27.47 70.10 REMARK 500 SER D 92 34.44 -60.08 REMARK 500 ASP D 93 42.34 -171.58 REMARK 500 SER D 148 -31.33 -39.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 0 MSE A 1 -132.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: APC29699 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THERE IS A MUTATION F7L FROM REMARK 999 UNKNOWN SOURCE IN COMPARISON TO THE DATABASE REMARK 999 SEQUENCE. DBREF 2OQT A 1 161 UNP Q9A1N7 Q9A1N7_STRP1 1 161 DBREF 2OQT B 1 161 UNP Q9A1N7 Q9A1N7_STRP1 1 161 DBREF 2OQT C 1 161 UNP Q9A1N7 Q9A1N7_STRP1 1 161 DBREF 2OQT D 1 161 UNP Q9A1N7 Q9A1N7_STRP1 1 161 SEQADV 2OQT ALA A 0 UNP Q9A1N7 CLONING ARTIFACT SEQADV 2OQT MSE A 1 UNP Q9A1N7 MET 1 MODIFIED RESIDUE SEQADV 2OQT LEU A 7 UNP Q9A1N7 PHE 7 SEE REMARK 999 SEQADV 2OQT MSE A 61 UNP Q9A1N7 MET 61 MODIFIED RESIDUE SEQADV 2OQT MSE A 64 UNP Q9A1N7 MET 64 MODIFIED RESIDUE SEQADV 2OQT MSE A 66 UNP Q9A1N7 MET 66 MODIFIED RESIDUE SEQADV 2OQT MSE A 144 UNP Q9A1N7 MET 144 MODIFIED RESIDUE SEQADV 2OQT MSE A 157 UNP Q9A1N7 MET 157 MODIFIED RESIDUE SEQADV 2OQT ALA B 0 UNP Q9A1N7 CLONING ARTIFACT SEQADV 2OQT MSE B 1 UNP Q9A1N7 MET 1 MODIFIED RESIDUE SEQADV 2OQT LEU B 7 UNP Q9A1N7 PHE 7 SEE REMARK 999 SEQADV 2OQT MSE B 61 UNP Q9A1N7 MET 61 MODIFIED RESIDUE SEQADV 2OQT MSE B 64 UNP Q9A1N7 MET 64 MODIFIED RESIDUE SEQADV 2OQT MSE B 66 UNP Q9A1N7 MET 66 MODIFIED RESIDUE SEQADV 2OQT MSE B 144 UNP Q9A1N7 MET 144 MODIFIED RESIDUE SEQADV 2OQT MSE B 157 UNP Q9A1N7 MET 157 MODIFIED RESIDUE SEQADV 2OQT ALA C 0 UNP Q9A1N7 CLONING ARTIFACT SEQADV 2OQT MSE C 1 UNP Q9A1N7 MET 1 MODIFIED RESIDUE SEQADV 2OQT LEU C 7 UNP Q9A1N7 PHE 7 SEE REMARK 999 SEQADV 2OQT MSE C 61 UNP Q9A1N7 MET 61 MODIFIED RESIDUE SEQADV 2OQT MSE C 64 UNP Q9A1N7 MET 64 MODIFIED RESIDUE SEQADV 2OQT MSE C 66 UNP Q9A1N7 MET 66 MODIFIED RESIDUE SEQADV 2OQT MSE C 144 UNP Q9A1N7 MET 144 MODIFIED RESIDUE SEQADV 2OQT MSE C 157 UNP Q9A1N7 MET 157 MODIFIED RESIDUE SEQADV 2OQT ALA D 0 UNP Q9A1N7 CLONING ARTIFACT SEQADV 2OQT MSE D 1 UNP Q9A1N7 MET 1 MODIFIED RESIDUE SEQADV 2OQT LEU D 7 UNP Q9A1N7 PHE 7 SEE REMARK 999 SEQADV 2OQT MSE D 61 UNP Q9A1N7 MET 61 MODIFIED RESIDUE SEQADV 2OQT MSE D 64 UNP Q9A1N7 MET 64 MODIFIED RESIDUE SEQADV 2OQT MSE D 66 UNP Q9A1N7 MET 66 MODIFIED RESIDUE SEQADV 2OQT MSE D 144 UNP Q9A1N7 MET 144 MODIFIED RESIDUE SEQADV 2OQT MSE D 157 UNP Q9A1N7 MET 157 MODIFIED RESIDUE SEQRES 1 A 162 ALA MSE ASN LEU LYS GLN ALA LEU ILE ASP ASN ASN SER SEQRES 2 A 162 ILE ARG LEU GLY LEU SER ALA ASP THR TRP GLN GLU ALA SEQRES 3 A 162 VAL ARG LEU ALA VAL GLN PRO LEU ILE ASP SER LYS ALA SEQRES 4 A 162 VAL THR SER ALA TYR TYR ASP ALA ILE ILE ALA SER THR SEQRES 5 A 162 GLU LYS TYR GLY PRO TYR TYR VAL LEU MSE PRO GLY MSE SEQRES 6 A 162 ALA MSE PRO HIS ALA GLU ALA GLY LEU GLY VAL ASN ARG SEQRES 7 A 162 ASN ALA PHE ALA LEU ILE THR LEU THR LYS PRO VAL THR SEQRES 8 A 162 PHE SER ASP GLY LYS GLU VAL SER VAL LEU LEU THR LEU SEQRES 9 A 162 ALA ALA THR ASP PRO SER ILE HIS THR THR VAL ALA ILE SEQRES 10 A 162 PRO GLN ILE VAL ALA LEU PHE GLU LEU ASP ASN ALA ILE SEQRES 11 A 162 GLU ARG LEU VAL ALA CYS GLN SER PRO LYS GLU VAL LEU SEQRES 12 A 162 GLU MSE VAL GLU GLU SER LYS ASP SER PRO TYR LEU GLU SEQRES 13 A 162 GLY MSE ASP LEU ASN ALA SEQRES 1 B 162 ALA MSE ASN LEU LYS GLN ALA LEU ILE ASP ASN ASN SER SEQRES 2 B 162 ILE ARG LEU GLY LEU SER ALA ASP THR TRP GLN GLU ALA SEQRES 3 B 162 VAL ARG LEU ALA VAL GLN PRO LEU ILE ASP SER LYS ALA SEQRES 4 B 162 VAL THR SER ALA TYR TYR ASP ALA ILE ILE ALA SER THR SEQRES 5 B 162 GLU LYS TYR GLY PRO TYR TYR VAL LEU MSE PRO GLY MSE SEQRES 6 B 162 ALA MSE PRO HIS ALA GLU ALA GLY LEU GLY VAL ASN ARG SEQRES 7 B 162 ASN ALA PHE ALA LEU ILE THR LEU THR LYS PRO VAL THR SEQRES 8 B 162 PHE SER ASP GLY LYS GLU VAL SER VAL LEU LEU THR LEU SEQRES 9 B 162 ALA ALA THR ASP PRO SER ILE HIS THR THR VAL ALA ILE SEQRES 10 B 162 PRO GLN ILE VAL ALA LEU PHE GLU LEU ASP ASN ALA ILE SEQRES 11 B 162 GLU ARG LEU VAL ALA CYS GLN SER PRO LYS GLU VAL LEU SEQRES 12 B 162 GLU MSE VAL GLU GLU SER LYS ASP SER PRO TYR LEU GLU SEQRES 13 B 162 GLY MSE ASP LEU ASN ALA SEQRES 1 C 162 ALA MSE ASN LEU LYS GLN ALA LEU ILE ASP ASN ASN SER SEQRES 2 C 162 ILE ARG LEU GLY LEU SER ALA ASP THR TRP GLN GLU ALA SEQRES 3 C 162 VAL ARG LEU ALA VAL GLN PRO LEU ILE ASP SER LYS ALA SEQRES 4 C 162 VAL THR SER ALA TYR TYR ASP ALA ILE ILE ALA SER THR SEQRES 5 C 162 GLU LYS TYR GLY PRO TYR TYR VAL LEU MSE PRO GLY MSE SEQRES 6 C 162 ALA MSE PRO HIS ALA GLU ALA GLY LEU GLY VAL ASN ARG SEQRES 7 C 162 ASN ALA PHE ALA LEU ILE THR LEU THR LYS PRO VAL THR SEQRES 8 C 162 PHE SER ASP GLY LYS GLU VAL SER VAL LEU LEU THR LEU SEQRES 9 C 162 ALA ALA THR ASP PRO SER ILE HIS THR THR VAL ALA ILE SEQRES 10 C 162 PRO GLN ILE VAL ALA LEU PHE GLU LEU ASP ASN ALA ILE SEQRES 11 C 162 GLU ARG LEU VAL ALA CYS GLN SER PRO LYS GLU VAL LEU SEQRES 12 C 162 GLU MSE VAL GLU GLU SER LYS ASP SER PRO TYR LEU GLU SEQRES 13 C 162 GLY MSE ASP LEU ASN ALA SEQRES 1 D 162 ALA MSE ASN LEU LYS GLN ALA LEU ILE ASP ASN ASN SER SEQRES 2 D 162 ILE ARG LEU GLY LEU SER ALA ASP THR TRP GLN GLU ALA SEQRES 3 D 162 VAL ARG LEU ALA VAL GLN PRO LEU ILE ASP SER LYS ALA SEQRES 4 D 162 VAL THR SER ALA TYR TYR ASP ALA ILE ILE ALA SER THR SEQRES 5 D 162 GLU LYS TYR GLY PRO TYR TYR VAL LEU MSE PRO GLY MSE SEQRES 6 D 162 ALA MSE PRO HIS ALA GLU ALA GLY LEU GLY VAL ASN ARG SEQRES 7 D 162 ASN ALA PHE ALA LEU ILE THR LEU THR LYS PRO VAL THR SEQRES 8 D 162 PHE SER ASP GLY LYS GLU VAL SER VAL LEU LEU THR LEU SEQRES 9 D 162 ALA ALA THR ASP PRO SER ILE HIS THR THR VAL ALA ILE SEQRES 10 D 162 PRO GLN ILE VAL ALA LEU PHE GLU LEU ASP ASN ALA ILE SEQRES 11 D 162 GLU ARG LEU VAL ALA CYS GLN SER PRO LYS GLU VAL LEU SEQRES 12 D 162 GLU MSE VAL GLU GLU SER LYS ASP SER PRO TYR LEU GLU SEQRES 13 D 162 GLY MSE ASP LEU ASN ALA MODRES 2OQT MSE A 1 MET SELENOMETHIONINE MODRES 2OQT MSE A 61 MET SELENOMETHIONINE MODRES 2OQT MSE A 64 MET SELENOMETHIONINE MODRES 2OQT MSE A 66 MET SELENOMETHIONINE MODRES 2OQT MSE A 144 MET SELENOMETHIONINE MODRES 2OQT MSE B 1 MET SELENOMETHIONINE MODRES 2OQT MSE B 61 MET SELENOMETHIONINE MODRES 2OQT MSE B 64 MET SELENOMETHIONINE MODRES 2OQT MSE B 66 MET SELENOMETHIONINE MODRES 2OQT MSE B 144 MET SELENOMETHIONINE MODRES 2OQT MSE C 1 MET SELENOMETHIONINE MODRES 2OQT MSE C 61 MET SELENOMETHIONINE MODRES 2OQT MSE C 64 MET SELENOMETHIONINE MODRES 2OQT MSE C 66 MET SELENOMETHIONINE MODRES 2OQT MSE C 144 MET SELENOMETHIONINE MODRES 2OQT MSE D 1 MET SELENOMETHIONINE MODRES 2OQT MSE D 61 MET SELENOMETHIONINE MODRES 2OQT MSE D 64 MET SELENOMETHIONINE MODRES 2OQT MSE D 66 MET SELENOMETHIONINE MODRES 2OQT MSE D 144 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 61 8 HET MSE A 64 8 HET MSE A 66 8 HET MSE A 144 8 HET MSE B 1 8 HET MSE B 61 8 HET MSE B 64 8 HET MSE B 66 8 HET MSE B 144 8 HET MSE C 1 8 HET MSE C 61 8 HET MSE C 64 8 HET MSE C 66 8 HET MSE C 144 8 HET MSE D 1 8 HET MSE D 61 8 HET MSE D 64 8 HET MSE D 66 8 HET MSE D 144 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 20(C5 H11 N O2 SE) FORMUL 5 HOH *14(H2 O) HELIX 1 1 ASN A 2 ASN A 10 1 9 HELIX 2 2 THR A 21 SER A 36 1 16 HELIX 3 3 THR A 40 GLY A 55 1 16 HELIX 4 4 SER A 109 VAL A 114 1 6 HELIX 5 5 VAL A 114 GLU A 124 1 11 HELIX 6 6 ASN A 127 ALA A 134 1 8 HELIX 7 7 SER A 137 LYS A 149 1 13 HELIX 8 8 ASN B 2 ASN B 10 1 9 HELIX 9 9 THR B 21 SER B 36 1 16 HELIX 10 10 THR B 40 GLY B 55 1 16 HELIX 11 11 PRO B 108 VAL B 114 1 7 HELIX 12 12 VAL B 114 GLU B 124 1 11 HELIX 13 13 ASN B 127 CYS B 135 1 9 HELIX 14 14 SER B 137 SER B 148 1 12 HELIX 15 15 ASN C 2 ASN C 11 1 10 HELIX 16 16 THR C 21 SER C 36 1 16 HELIX 17 17 SER C 41 GLY C 55 1 15 HELIX 18 18 ASP C 107 LEU C 125 1 19 HELIX 19 19 ASN C 127 CYS C 135 1 9 HELIX 20 20 SER C 137 GLU C 147 1 11 HELIX 21 21 SER C 148 ASP C 150 5 3 HELIX 22 22 ASN D 2 ASN D 10 1 9 HELIX 23 23 THR D 21 ASP D 35 1 15 HELIX 24 24 THR D 40 GLY D 55 1 16 HELIX 25 25 ASP D 107 LEU D 125 1 19 HELIX 26 26 ASN D 127 ALA D 134 1 8 HELIX 27 27 SER D 137 LYS D 149 1 13 HELIX 28 28 ASP D 150 GLU D 155 5 6 SHEET 1 A 4 ILE A 13 LEU A 17 0 SHEET 2 A 4 LEU A 82 THR A 90 1 O THR A 84 N LEU A 17 SHEET 3 A 4 GLU A 96 LEU A 100 -1 O VAL A 97 N VAL A 89 SHEET 4 A 4 GLY A 63 ALA A 65 1 N GLY A 63 O SER A 98 SHEET 1 B 2 ALA A 79 PHE A 80 0 SHEET 2 B 2 LEU A 103 ALA A 104 -1 O ALA A 104 N ALA A 79 SHEET 1 C 4 ILE B 13 LEU B 17 0 SHEET 2 C 4 ALA B 79 THR B 90 1 O THR B 84 N LEU B 17 SHEET 3 C 4 GLU B 96 ALA B 104 -1 O LEU B 100 N ILE B 83 SHEET 4 C 4 GLY B 63 ALA B 65 1 N ALA B 65 O LEU B 101 SHEET 1 D 4 ILE C 13 LEU C 17 0 SHEET 2 D 4 LEU C 82 THR C 90 1 O THR C 86 N LEU C 17 SHEET 3 D 4 GLU C 96 LEU C 100 -1 O VAL C 97 N VAL C 89 SHEET 4 D 4 GLY C 63 ALA C 65 1 N GLY C 63 O GLU C 96 SHEET 1 E 2 ALA C 79 PHE C 80 0 SHEET 2 E 2 LEU C 103 ALA C 104 -1 O ALA C 104 N ALA C 79 SHEET 1 F 4 ILE D 13 LEU D 17 0 SHEET 2 F 4 LEU D 82 THR D 90 1 O LEU D 82 N ARG D 14 SHEET 3 F 4 GLU D 96 LEU D 100 -1 O SER D 98 N LEU D 85 SHEET 4 F 4 GLY D 63 ALA D 65 1 N GLY D 63 O GLU D 96 SHEET 1 G 2 ALA D 79 PHE D 80 0 SHEET 2 G 2 LEU D 103 ALA D 104 -1 O ALA D 104 N ALA D 79 LINK C ALA A 0 N MSE A 1 1555 1555 1.34 LINK C MSE A 1 N ASN A 2 1555 1555 1.33 LINK C LEU A 60 N MSE A 61 1555 1555 1.33 LINK C MSE A 61 N PRO A 62 1555 1555 1.36 LINK C GLY A 63 N MSE A 64 1555 1555 1.33 LINK C MSE A 64 N ALA A 65 1555 1555 1.34 LINK C ALA A 65 N MSE A 66 1555 1555 1.32 LINK C MSE A 66 N PRO A 67 1555 1555 1.34 LINK C GLU A 143 N MSE A 144 1555 1555 1.33 LINK C MSE A 144 N VAL A 145 1555 1555 1.34 LINK C ALA B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N ASN B 2 1555 1555 1.33 LINK C LEU B 60 N MSE B 61 1555 1555 1.32 LINK C MSE B 61 N PRO B 62 1555 1555 1.34 LINK C GLY B 63 N MSE B 64 1555 1555 1.33 LINK C MSE B 64 N ALA B 65 1555 1555 1.33 LINK C ALA B 65 N MSE B 66 1555 1555 1.33 LINK C MSE B 66 N PRO B 67 1555 1555 1.33 LINK C GLU B 143 N MSE B 144 1555 1555 1.34 LINK C MSE B 144 N VAL B 145 1555 1555 1.33 LINK C ALA C 0 N MSE C 1 1555 1555 1.34 LINK C MSE C 1 N ASN C 2 1555 1555 1.32 LINK C LEU C 60 N MSE C 61 1555 1555 1.34 LINK C MSE C 61 N PRO C 62 1555 1555 1.36 LINK C GLY C 63 N MSE C 64 1555 1555 1.33 LINK C MSE C 64 N ALA C 65 1555 1555 1.33 LINK C ALA C 65 N MSE C 66 1555 1555 1.33 LINK C MSE C 66 N PRO C 67 1555 1555 1.34 LINK C GLU C 143 N MSE C 144 1555 1555 1.34 LINK C MSE C 144 N VAL C 145 1555 1555 1.34 LINK C ALA D 0 N MSE D 1 1555 1555 1.34 LINK C MSE D 1 N ASN D 2 1555 1555 1.34 LINK C LEU D 60 N MSE D 61 1555 1555 1.34 LINK C MSE D 61 N PRO D 62 1555 1555 1.34 LINK C GLY D 63 N MSE D 64 1555 1555 1.34 LINK C MSE D 64 N ALA D 65 1555 1555 1.33 LINK C ALA D 65 N MSE D 66 1555 1555 1.33 LINK C MSE D 66 N PRO D 67 1555 1555 1.36 LINK C GLU D 143 N MSE D 144 1555 1555 1.33 LINK C MSE D 144 N VAL D 145 1555 1555 1.33 CISPEP 1 SER C 151 PRO C 152 0 13.77 CISPEP 2 PRO C 152 TYR C 153 0 -19.33 CRYST1 51.224 112.781 60.401 90.00 99.19 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019522 0.000000 0.003158 0.00000 SCALE2 0.000000 0.008867 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016771 0.00000